LHC Group (LHCG) Rating Increased to Hold at Zacks Investment Research

Zacks Investment Research upgraded shares of LHC Group (NASDAQ:LHCG) from a sell rating to a hold rating in a research note published on Saturday morning, Zacks.com reports.

According to Zacks, “LHC Group, Inc. is the preferred post-acute care partner for hospitals, physicians and families nationwide. From home health and hospice care to long-term acute care and community-based services, LHC delivers high-quality, cost-effective care that empowers patients to manage their health at home. Hospitals and health systems around the country have partnered with LHC Group to deliver patient-centered care in the home. “

LHCG has been the topic of a number of other research reports. BidaskClub downgraded shares of LHC Group from a strong-buy rating to a buy rating in a research report on Thursday, February 28th. Barclays boosted their target price on shares of LHC Group from $95.00 to $104.00 and gave the company an equal weight rating in a research report on Thursday, March 21st. Craig Hallum boosted their target price on shares of LHC Group from $93.00 to $114.00 and gave the company a hold rating in a research report on Friday, March 1st. They noted that the move was a valuation call. Jefferies Financial Group boosted their target price on shares of LHC Group from $125.00 to $130.00 and gave the company a buy rating in a research report on Thursday, May 9th. Finally, SunTrust Banks boosted their target price on shares of LHC Group to $130.00 and gave the company a buy rating in a research report on Friday, March 1st. Four research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. The stock has a consensus rating of Buy and an average target price of $118.50.



NASDAQ:LHCG opened at $115.39 on Friday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.78 and a current ratio of 1.57. LHC Group has a 52 week low of $73.00 and a 52 week high of $116.74. The firm has a market capitalization of $3.62 billion, a PE ratio of 32.50, a PEG ratio of 1.96 and a beta of 0.87.

LHC Group (NASDAQ:LHCG) last released its earnings results on Wednesday, May 8th. The health services provider reported $0.98 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.90 by $0.08. LHC Group had a net margin of 3.83% and a return on equity of 8.43%. The company had revenue of $502.59 million for the quarter, compared to the consensus estimate of $511.16 million. Equities research analysts forecast that LHC Group will post 4.3 earnings per share for the current year.

In other LHC Group news, EVP Joshua L. Proffitt sold 11,003 shares of the company’s stock in a transaction on Monday, March 11th. The shares were sold at an average price of $107.36, for a total transaction of $1,181,282.08. Following the transaction, the executive vice president now owns 66,980 shares in the company, valued at $7,190,972.80. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Keith G. Myers sold 75,000 shares of the company’s stock in a transaction on Friday, March 1st. The stock was sold at an average price of $108.53, for a total transaction of $8,139,750.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 117,876 shares of company stock worth $12,762,540. Corporate insiders own 5.20% of the company’s stock.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Citigroup Inc. grew its stake in shares of LHC Group by 265.2% in the 4th quarter. Citigroup Inc. now owns 4,386 shares of the health services provider’s stock worth $412,000 after acquiring an additional 3,185 shares in the last quarter. Eqis Capital Management Inc. grew its stake in shares of LHC Group by 6.2% in the 4th quarter. Eqis Capital Management Inc. now owns 4,837 shares of the health services provider’s stock worth $454,000 after acquiring an additional 281 shares in the last quarter. Campbell Newman Asset Management Inc. grew its stake in shares of LHC Group by 2.4% in the 1st quarter. Campbell Newman Asset Management Inc. now owns 6,350 shares of the health services provider’s stock worth $704,000 after acquiring an additional 151 shares in the last quarter. HMS Capital Management LLC bought a new stake in shares of LHC Group in the 4th quarter worth $238,000. Finally, Financial Gravity Companies Inc. bought a new stake in shares of LHC Group in the 4th quarter worth $49,000. Hedge funds and other institutional investors own 92.78% of the company’s stock.

About LHC Group

LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.

Further Reading: Dollar Cost Averaging

Get a free copy of the Zacks research report on LHC Group (LHCG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.